These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 8978581

  • 1. UFT modulated with leucovorin in advanced colorectal cancer: Oncopaz experience.
    González Barón M, Feliu J, Garcia Girón C, Espinosa J, Martinez B, Blanco E, Crespo MC, Ordóñez A, Espinosa E, de Castro J, Juárez F, Colmenarejo A.
    Oncology; 1997; 54 Suppl 1():24-9. PubMed ID: 8978581
    [Abstract] [Full Text] [Related]

  • 2. Uracil and tegafur modulated with leucovorin: an effective regimen with low toxicity for the treatment of colorectal carcinoma in the elderly. Oncopaz Cooperative Group.
    Feliu J, González Barón M, Espinosa E, García Girón C, de la Gándara I, Espinosa J, Colmenarejo A, Jalón JI, Fernández Y, de Castro J.
    Cancer; 1997 May 15; 79(10):1884-9. PubMed ID: 9149013
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of patients with advanced gastric carcinoma with the combination of etoposide plus oral tegafur modulated by uracil and leucovorin. A phase II study of the ONCOPAZ Cooperative Group.
    Feliu J, González Barón M, García-Girón C, Espinosa E, García-Alfonso P, Belón J, Blanco E, Garrido P, Ordónez A, Gómez-Navarro J, Zamora P.
    Cancer; 1996 Jul 15; 78(2):211-6. PubMed ID: 8673994
    [Abstract] [Full Text] [Related]

  • 11. Phase II study of UFT plus leucovorin in colorectal cancer.
    Pazdur R.
    Oncology; 1997 Jul 15; 54 Suppl 1():19-23. PubMed ID: 8978580
    [Abstract] [Full Text] [Related]

  • 12. A phase II trial. Oral UFT and leucovorin in patients with advanced gastric carcinoma.
    Kim YH, Shin SW, Kim BS, Park YT, Kim JG, Kim JS.
    Oncology (Williston Park); 1997 Sep 15; 11(9 Suppl 10):119-23. PubMed ID: 9348583
    [Abstract] [Full Text] [Related]

  • 13. UFT/leucovorin plus irinotecan in advanced or metastatic colorectal cancer.
    Price T, Hill M.
    Oncology (Williston Park); 2000 Oct 15; 14(10 Suppl 9):28-31. PubMed ID: 11098487
    [Abstract] [Full Text] [Related]

  • 14. The UFT/leucovorin/etoposide regimen for the treatment of advanced gastric cancer. Oncopaz Cooperative Group.
    González Barón M, Espinosa E, Feliu J, Ordóñez A, Zamora P, de Castro J, García Girón C, García Alfonso P, Garrido P, Belón J, Lomas M.
    Oncology (Williston Park); 1997 Sep 15; 11(9 Suppl 10):109-12. PubMed ID: 9348581
    [Abstract] [Full Text] [Related]

  • 15. A phase I/II study of oral uracil/tegafur (UFT), leucovorin and irinotecan in patients with advanced colorectal cancer.
    Mackay HJ, Hill M, Twelves C, Glasspool R, Price T, Campbell S, Massey A, Macham MA, Uzzel M, Bailey SM, Martin C, Cunningham D.
    Ann Oncol; 2003 Aug 15; 14(8):1264-9. PubMed ID: 12881390
    [Abstract] [Full Text] [Related]

  • 16. [Efficacy of uracil/tegafur (UFT) plus oral Leucovorin (LV) therapy for colorectal cancer in elderly patients].
    Mizushima T, Mizuno H, Ito T, Hoki M, Souma Y, Iwamoto T, Ozawa H, Kanou T, Nakamori Y, Iwase K.
    Gan To Kagaku Ryoho; 2006 Jul 15; 33(7):941-4. PubMed ID: 16835484
    [Abstract] [Full Text] [Related]

  • 17. Phase II study of uracil-tegafur with leucovorin in elderly (> or = 75 years old) patients with colorectal cancer: ECOG 1299.
    Hochster HS, Luo W, Popa EC, Lyman BT, Mulcahy M, Beatty PA, Benson AB.
    J Clin Oncol; 2007 Dec 01; 25(34):5397-402. PubMed ID: 18048821
    [Abstract] [Full Text] [Related]

  • 18. Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced pancreatic carcinoma: a University of Chicago phase II consortium study.
    Mani S, Kugler JW, Sciortino DF, Garcia JC, Ansari RH, Humerickhouse R, Michelassi F, Posner MC, Shulman KL, Schilsky RL, List M, Vokes EE, Benner S.
    Ann Oncol; 1998 Sep 01; 9(9):1035-7. PubMed ID: 9818081
    [Abstract] [Full Text] [Related]

  • 19. Retrospective study of S-1 versus tegafur/uracil and oral leucovorin in patients with metastatic colorectal cancer.
    Shibahara K, Yamamoto M, Kakeji Y, Sakata H, Maehara Y.
    Anticancer Res; 2008 Sep 01; 28(3B):1779-83. PubMed ID: 18630459
    [Abstract] [Full Text] [Related]

  • 20. Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced biliary carcinoma.
    Mani S, Sciortino D, Samuels B, Arrietta R, Schilsky RL, Vokes EE, Benner S.
    Invest New Drugs; 1999 Sep 01; 17(1):97-101. PubMed ID: 10555128
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.